Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Allergan prepares new sodium channel blockers

July 25, 2013

Valproic acid analogue evaluated for antimigraine potential

July 25, 2013

Northeastern University discloses new CB1 receptor modulators

July 25, 2013

Questcor to commence screening for phase II study of H.P. Acthar Gel in ALS

July 25, 2013

Sarepta plans eteplirsen NDA submission

July 25, 2013

New Alzheimer's disease model is based on N-truncated Abeta4-42 expression

July 25, 2013

U.S. team discovers new monoacylglycerol lipase inhibitors

July 25, 2013

Charleston Laboratories completes pre-IND meeting regarding migraine treatment

July 24, 2013

Results of a phase I evaluation of antigen-specific tolerance for multiple sclerosis

July 24, 2013

Noven Pharmaceuticals reports topline results from phase II d-ATS

July 24, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...